Antiviral drug invented by Emory’s DRIVE licensed in India for COVID-19 emergency
To address the intensifying COVID-19 crisis in India, the pharmaceutical company Merck has agreed to facilitate the manufacture and distribution of molnupiravir, an investigational antiviral drug that was discovered at Emory.
RSSRecent News Releases »
Faculty Opinion »
Opinion: COVID has made getting into a top U.S. college even more competitive and this new normal looks here to stay
Afghans want peace. New data show they’re open to a surprising number of options.
COVID variant could mean a brutal March for the US
I've lived in both Americas. Most people everywhere don't want to hate each other
How to reassure Black Americans that the vaccine is safe
Featured Expert »
Andra Gillespie, Politics
Political scientist Andra Gillespie specializes in political mobilization and race and is the author of "The New Black Politician: Cory Booker, Newark and Post-Racial America."
Video »
How customized antibiotic combinations could defeat 'superbugs'
A sneaky form of antibiotic resistance called "heteroresistance" is more widespread than previously appreciated. But tracking heteroresistance might guide the choice of antibiotic combinations that can defeat bacteria regarded as invincible.
Emory in the News »
A gift left the Morehouse Class of ’19 debt-free. Here’s how it’s changing their lives
Marketplace, May 13
CDC says fully vaccinated Americans no longer need masks indoors or outdoors in many cases
Washington Post, May 13
Hundreds of epidemiologists expected mask-wearing in public for at least a year
New York Times, May 13
Pfizer, Moderna COVID-19 vaccines likely effective against Indian coronavirus variant, researchers suggest
FOX News, May 12
- Emory Healthcare CEO Jonathan Lewin in a joint CNN column with Delta CEO Ed Bastian
